SWIFT-seq on STAT News!

Written By RSP

STAT News featured an article on SWIFT-seq, our single-cell sequencing-based assay to measure and molecularly profile circulating tumor cells (CTCs) in patients with Multiple Myeloma and its precursor conditions.

Read the article here.

RSP
Next

Dr. Sklavenitis Pistofidis speaks at #ASH25 about genomic & immune biomarkers of progression to MM